Life Sciences Tools and Services
Company Overview of inVentiv Health Inc.
inVentiv Health Inc. provides value-added services to the pharmaceutical and life sciences industries in the U.S. and internationally. The company supports a range of clinical development, communications, and commercialization activities critical to developing new drug products and medical devices. Its inVentiv Clinical segment provides services related to permanent placement, clinical staffing, data collection and management, and functional outsourcing. The inVentiv Communications segment furnishes advertising, communications, and other functionally related services. InVentiv Commercial provides commercialization services, including outsourced product commercialization programs; patient sup...
1 Van de Graaff Drive
Burlington, MA 01803
Founded in 1996
Key Executives for inVentiv Health Inc.
Executive Chairman and Chief Executive Officer
President of Smith Hanley Companies and Chief Executive Officer of Smith Hanley Companies
Chief Executive Officer of i3 Organization
Chief Executive Officer of Campbell Alliance
Senior Vice President of Marketing & Communications and President of Inventiv Health Communications
Compensation as of Fiscal Year 2013.
inVentiv Health Inc. Key Developments
inVentiv Health Inc. Appoints Michael A. Griffith as Executive Vice President
Mar 10 14
inVentiv Health Inc. announced that the appointment of Michael A. Griffith as Executive Vice President. In this capacity, Griffith will head the company's Commercial and Consulting businesses and report to the company Health CEO Paul Meister. Most recently, Griffith was the Chief Executive Officer of Laureate Biopharma.
NeuroVive Pharmaceutical Strengthens Partnership Agreement with inVentiv Health to Prepare for Upcoming Market Launch
Feb 3 14
NeuroVive Pharmaceutical AB announced that it has extended the partnership agreement with inVentiv Health. NeuroVive announced that it has been evaluating various collaborations with large pharmaceutical companies and contract research organizations to reduce risk and increase cost efficiencies. The company is currently in the planning stage for commercialization of its lead product, CicloMulsion, now in a Phase III study to determine the drug's effectiveness in reducing cardiac damage following stenting in heart attack patients. NeuroVive said that inVentiv Health works with pharmaceutical and biotechnology firms to help define alternatives to traditional development and commercialization models.
inVentiv Health Extends Partnership Agreement with NeuroVive Pharmaceutical AB
Jan 29 14
inVentiv Health announced the extension of its partnership with NeuroVive Pharmaceutical AB. inVentiv Health works with pharmaceutical and biotechnology firms to help define innovative alternatives to traditional development and commercialization models. inVentiv offers mid-size pharmaceutical and biopharmaceutical companies an expansive set of services that run from early-stage clinical development to full global commercialization. The breadth of inVentiv Health's services is unique in the industry and includes comprehensive drug development, risk management, market access and reimbursement, launch, marketing communications, payer relations and patient outcomes. NeuroVive, with a promising portfolio of mitochondrial drugs in development to treat acute cardiovascular and neurological conditions, has been evaluating various collaborations with large pharmaceutical companies and contract research organizations to reduce risk and increase cost efficiencies. They are currently in the planning stage for commercialization of their lead product, CicloMulsion(R), now in a Phase III study to determine the drug's effectiveness in reducing cardiac damage following stenting in heart attack patients. NeuroVive is looking for a partner with an alternative business model that can commercialize CicloMulsion(R) and be leveraged to scale for future products. By working with inVentiv, mid-size pharmaceutical companies maintain more control and value with the ability to move faster to market.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|